Gangloff Scott A. bought AKRO
June 30, 2025 · Form 4 insider transaction
Gangloff Scott A. bought 299 shares of Akero Therapeutics, Inc. at $23.87 per share, a transaction worth $7.1K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
299
Price
$23.87
Total value
$7.1K
InsiderGangloff Scott A.
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 30, 2025
Filing dateJuly 2, 2025
Shares owned after23,751
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Mr. Gangloff is voluntarily reporting the acquisition of these shares on June 30, 2025 pursuant to the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).; In accordance with the provisions of the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan, these shares were purchased at 85% of the closing price of the Issuer's common stock on January 2, 2025.